St Vincent's Hospital, Sydney

This study tests whether a high dose of testosterone combined with the chemotherapy drug carboplatin can help men with a specific type of advanced prostate cancer that has stopped responding to standard hormone therapy. About 30 men with a genetic defect called homologous recombi…

This early-phase study tests whether adding a new drug (roginolisib) to an existing treatment (tebentafusp) is safe and tolerable for people with advanced uveal melanoma, a rare eye cancer. The study enrolls 8 adults who are already receiving tebentafusp as their first treatment.…

This study talks to men with prostate cancer to learn how they feel about the risk of breast-related side effects, like breast growth, from their treatment. The goal is to understand what matters most to them when choosing treatments. The results will help doctors and patients ma…